The Executive Committee of the European Diagnostics Manufacturers Association (EDMA) and the Board of the European Medical Technology Industry Association (Eucomed), both members of MedTech Europe, in a continuous effort to reinforce their respective Codes of Ethical Business Practice today announce their recommendation to members to phase out by 1 January 2018 direct industry sponsorship of healthcare professionals (HCPs) to third-party organised conferences. Both associations are also recommending the introduction of stricter rules for indirect sponsorship. The MedTech industry remains committed to supporting the continuing medical education of HCPs and will continue its ongoing consultation with HCP organisations and other stakeholders to ensure that HCPs have access to the education they need.
MedTech Europe, the alliance of European medical technology industry associations, announces today the extension of the successful Eucomed Ethical Business Logo Programme to non-Eucomed members. The programme allows any MedTech company to have its compliance governance benchmarked against the industry standard. In a verification process designed with guidance from one of the Big Four global accounting firms, companies must demonstrate their commitment to ethical principles outlined in the Eucomed Code of Ethical Business Practice . The Logo serves as a visible signal to the outside world that a company is serious about compliance.
Eucomed, the European medical technology industry association, will launch in early 2012 a conference pre-vetting system to review and approve third-party educational conferences and congresses in accordance with the ethical rules established in the Eucomed Code of Ethical Business Practice. Falling under the responsibility of the independent Eucomed Compliance Panel, the system will be binding on Eucomed members who must comply with the conference appraisal assessments.